Modulation of gamma oscillations by endogenous adenosine through A1 and A2A receptors in the mouse hippocampus
Adenosine serves as a homeostatic factor, regulating hippocampal activity through A(1) receptor-mediated inhibition. Gamma frequency oscillations, associated with cognitive functions, emerge from increased network activity. Here we test the hypothesis that hippocampal gamma oscillations are modulate...
Gespeichert in:
Veröffentlicht in: | Neuropharmacology 2009-02, Vol.56 (2), p.481-492 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 492 |
---|---|
container_issue | 2 |
container_start_page | 481 |
container_title | Neuropharmacology |
container_volume | 56 |
creator | Pietersen, A N Lancaster, D M Patel, N Hamilton, J B Vreugdenhil, M |
description | Adenosine serves as a homeostatic factor, regulating hippocampal activity through A(1) receptor-mediated inhibition. Gamma frequency oscillations, associated with cognitive functions, emerge from increased network activity. Here we test the hypothesis that hippocampal gamma oscillations are modulated by ambient adenosine levels. In mouse hippocampal slices exogenous adenosine suppressed the power of both kainate-induced gamma oscillations and spontaneous gamma oscillations, observed in a subset of slices in normal aCSF. Kainate-induced gamma oscillation power was suppressed by the A(1) receptor agonist PIA and potentiated by the A(1) receptor antagonist 8-CPT to three times matched control values with an EC(50) of 1.1microM. 8-CPT also potentiated spontaneous gamma oscillation power to five times control values. The A(2A) receptor agonist CGS21680 potentiated kainate-induced gamma power to two times control values (EC(50) 0.3nM), but this effect was halved in the presence of 8-CPT. The A(2A) receptor antagonist ZM241385 suppressed kainate-induced gamma power. The non-selective adenosine receptor antagonist caffeine induced gamma oscillations in slices in control aCSF and potentiated both kainate-induced gamma and spontaneous gamma oscillations to three times control values (EC(50) 28muM). Decreasing endogenous adenosine levels with adenosine deaminase increased gamma oscillations. Increasing endogenous adenosine levels with the adenosine kinase inhibitor 5-iodotubericidin suppressed gamma oscillations. Partial hypoxia-induced suppression of gamma oscillations could be prevented by 8-CPT. These observations indicate that gamma oscillation strength is powerfully modulated by ambient levels of adenosine through A(1) receptors, opposed by A(2A) receptors. Increased gamma oscillation strength is likely to contribute to the beneficial cognitive effects of caffeine. |
doi_str_mv | 10.1016/j.neuropharm.2008.10.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20391074</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20391074</sourcerecordid><originalsourceid>FETCH-LOGICAL-c325t-a7052a078b7afa3a5ca987a9a778adfb0eb0ba43fa2313faff4a2f1606bc920f3</originalsourceid><addsrcrecordid>eNpFkD1PwzAQhj2AaCn8BeSJLeHsJI0zRhVfUhELzNbFsZtUjR3sZOi_x1UrdbmT7t73Ph5CKIOUAVu_7FOrZ-_GDv2QcgARyykAuyFLAC6SrAKxIPch7AEgF0zckQUTVVFAyZbEfrl2PuDUO0udoTscBqQuqP5wLgbaHKm2rdtp6-ZAsY059FbTqfNu3nW0ZhRtS2teU6-VHifnA-1t7Gs6RIumXT-OTuEwzuGB3Bo8BP14ySvy-_b6s_lItt_vn5t6m6iMF1OCJRQcoRRNiQYzLBRWosQKy1JgaxrQDTSYZwZ5xmI0Jkdu2BrWjao4mGxFns9zR-_-Zh0mOfRB6fiU1fEmySGrGJR5FIqzUHkXgtdGjr4f0B8lA3niK_fyylee-J46kW-0Pl12zM2g26vxAjf7BwHIfyo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20391074</pqid></control><display><type>article</type><title>Modulation of gamma oscillations by endogenous adenosine through A1 and A2A receptors in the mouse hippocampus</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Pietersen, A N ; Lancaster, D M ; Patel, N ; Hamilton, J B ; Vreugdenhil, M</creator><creatorcontrib>Pietersen, A N ; Lancaster, D M ; Patel, N ; Hamilton, J B ; Vreugdenhil, M</creatorcontrib><description>Adenosine serves as a homeostatic factor, regulating hippocampal activity through A(1) receptor-mediated inhibition. Gamma frequency oscillations, associated with cognitive functions, emerge from increased network activity. Here we test the hypothesis that hippocampal gamma oscillations are modulated by ambient adenosine levels. In mouse hippocampal slices exogenous adenosine suppressed the power of both kainate-induced gamma oscillations and spontaneous gamma oscillations, observed in a subset of slices in normal aCSF. Kainate-induced gamma oscillation power was suppressed by the A(1) receptor agonist PIA and potentiated by the A(1) receptor antagonist 8-CPT to three times matched control values with an EC(50) of 1.1microM. 8-CPT also potentiated spontaneous gamma oscillation power to five times control values. The A(2A) receptor agonist CGS21680 potentiated kainate-induced gamma power to two times control values (EC(50) 0.3nM), but this effect was halved in the presence of 8-CPT. The A(2A) receptor antagonist ZM241385 suppressed kainate-induced gamma power. The non-selective adenosine receptor antagonist caffeine induced gamma oscillations in slices in control aCSF and potentiated both kainate-induced gamma and spontaneous gamma oscillations to three times control values (EC(50) 28muM). Decreasing endogenous adenosine levels with adenosine deaminase increased gamma oscillations. Increasing endogenous adenosine levels with the adenosine kinase inhibitor 5-iodotubericidin suppressed gamma oscillations. Partial hypoxia-induced suppression of gamma oscillations could be prevented by 8-CPT. These observations indicate that gamma oscillation strength is powerfully modulated by ambient levels of adenosine through A(1) receptors, opposed by A(2A) receptors. Increased gamma oscillation strength is likely to contribute to the beneficial cognitive effects of caffeine.</description><identifier>ISSN: 0028-3908</identifier><identifier>DOI: 10.1016/j.neuropharm.2008.10.001</identifier><identifier>PMID: 18955071</identifier><language>eng</language><publisher>England</publisher><subject>Adenosine - analogs & derivatives ; Adenosine - pharmacology ; Adenosine A1 Receptor Antagonists ; Adenosine A2 Receptor Antagonists ; Analysis of Variance ; Animals ; Biological Clocks - drug effects ; Dose-Response Relationship, Drug ; Evoked Potentials - drug effects ; Evoked Potentials - physiology ; Excitatory Amino Acid Agonists - pharmacology ; Fourier Analysis ; Hippocampus - drug effects ; Hippocampus - physiology ; Hypoxia - physiopathology ; In Vitro Techniques ; Kainic Acid - pharmacology ; Male ; Mice ; Mice, Inbred C57BL ; Phenethylamines - pharmacology ; Receptor, Adenosine A1 - physiology ; Receptor, Adenosine A2A - physiology ; Theophylline - analogs & derivatives ; Theophylline - pharmacology ; Thioinosine - analogs & derivatives ; Thioinosine - pharmacology ; Time Factors ; Triazines - pharmacology ; Triazoles - pharmacology</subject><ispartof>Neuropharmacology, 2009-02, Vol.56 (2), p.481-492</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c325t-a7052a078b7afa3a5ca987a9a778adfb0eb0ba43fa2313faff4a2f1606bc920f3</citedby><cites>FETCH-LOGICAL-c325t-a7052a078b7afa3a5ca987a9a778adfb0eb0ba43fa2313faff4a2f1606bc920f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18955071$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pietersen, A N</creatorcontrib><creatorcontrib>Lancaster, D M</creatorcontrib><creatorcontrib>Patel, N</creatorcontrib><creatorcontrib>Hamilton, J B</creatorcontrib><creatorcontrib>Vreugdenhil, M</creatorcontrib><title>Modulation of gamma oscillations by endogenous adenosine through A1 and A2A receptors in the mouse hippocampus</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>Adenosine serves as a homeostatic factor, regulating hippocampal activity through A(1) receptor-mediated inhibition. Gamma frequency oscillations, associated with cognitive functions, emerge from increased network activity. Here we test the hypothesis that hippocampal gamma oscillations are modulated by ambient adenosine levels. In mouse hippocampal slices exogenous adenosine suppressed the power of both kainate-induced gamma oscillations and spontaneous gamma oscillations, observed in a subset of slices in normal aCSF. Kainate-induced gamma oscillation power was suppressed by the A(1) receptor agonist PIA and potentiated by the A(1) receptor antagonist 8-CPT to three times matched control values with an EC(50) of 1.1microM. 8-CPT also potentiated spontaneous gamma oscillation power to five times control values. The A(2A) receptor agonist CGS21680 potentiated kainate-induced gamma power to two times control values (EC(50) 0.3nM), but this effect was halved in the presence of 8-CPT. The A(2A) receptor antagonist ZM241385 suppressed kainate-induced gamma power. The non-selective adenosine receptor antagonist caffeine induced gamma oscillations in slices in control aCSF and potentiated both kainate-induced gamma and spontaneous gamma oscillations to three times control values (EC(50) 28muM). Decreasing endogenous adenosine levels with adenosine deaminase increased gamma oscillations. Increasing endogenous adenosine levels with the adenosine kinase inhibitor 5-iodotubericidin suppressed gamma oscillations. Partial hypoxia-induced suppression of gamma oscillations could be prevented by 8-CPT. These observations indicate that gamma oscillation strength is powerfully modulated by ambient levels of adenosine through A(1) receptors, opposed by A(2A) receptors. Increased gamma oscillation strength is likely to contribute to the beneficial cognitive effects of caffeine.</description><subject>Adenosine - analogs & derivatives</subject><subject>Adenosine - pharmacology</subject><subject>Adenosine A1 Receptor Antagonists</subject><subject>Adenosine A2 Receptor Antagonists</subject><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Biological Clocks - drug effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Evoked Potentials - drug effects</subject><subject>Evoked Potentials - physiology</subject><subject>Excitatory Amino Acid Agonists - pharmacology</subject><subject>Fourier Analysis</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - physiology</subject><subject>Hypoxia - physiopathology</subject><subject>In Vitro Techniques</subject><subject>Kainic Acid - pharmacology</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Phenethylamines - pharmacology</subject><subject>Receptor, Adenosine A1 - physiology</subject><subject>Receptor, Adenosine A2A - physiology</subject><subject>Theophylline - analogs & derivatives</subject><subject>Theophylline - pharmacology</subject><subject>Thioinosine - analogs & derivatives</subject><subject>Thioinosine - pharmacology</subject><subject>Time Factors</subject><subject>Triazines - pharmacology</subject><subject>Triazoles - pharmacology</subject><issn>0028-3908</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkD1PwzAQhj2AaCn8BeSJLeHsJI0zRhVfUhELzNbFsZtUjR3sZOi_x1UrdbmT7t73Ph5CKIOUAVu_7FOrZ-_GDv2QcgARyykAuyFLAC6SrAKxIPch7AEgF0zckQUTVVFAyZbEfrl2PuDUO0udoTscBqQuqP5wLgbaHKm2rdtp6-ZAsY059FbTqfNu3nW0ZhRtS2teU6-VHifnA-1t7Gs6RIumXT-OTuEwzuGB3Bo8BP14ySvy-_b6s_lItt_vn5t6m6iMF1OCJRQcoRRNiQYzLBRWosQKy1JgaxrQDTSYZwZ5xmI0Jkdu2BrWjao4mGxFns9zR-_-Zh0mOfRB6fiU1fEmySGrGJR5FIqzUHkXgtdGjr4f0B8lA3niK_fyylee-J46kW-0Pl12zM2g26vxAjf7BwHIfyo</recordid><startdate>200902</startdate><enddate>200902</enddate><creator>Pietersen, A N</creator><creator>Lancaster, D M</creator><creator>Patel, N</creator><creator>Hamilton, J B</creator><creator>Vreugdenhil, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>200902</creationdate><title>Modulation of gamma oscillations by endogenous adenosine through A1 and A2A receptors in the mouse hippocampus</title><author>Pietersen, A N ; Lancaster, D M ; Patel, N ; Hamilton, J B ; Vreugdenhil, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c325t-a7052a078b7afa3a5ca987a9a778adfb0eb0ba43fa2313faff4a2f1606bc920f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adenosine - analogs & derivatives</topic><topic>Adenosine - pharmacology</topic><topic>Adenosine A1 Receptor Antagonists</topic><topic>Adenosine A2 Receptor Antagonists</topic><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Biological Clocks - drug effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Evoked Potentials - drug effects</topic><topic>Evoked Potentials - physiology</topic><topic>Excitatory Amino Acid Agonists - pharmacology</topic><topic>Fourier Analysis</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - physiology</topic><topic>Hypoxia - physiopathology</topic><topic>In Vitro Techniques</topic><topic>Kainic Acid - pharmacology</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Phenethylamines - pharmacology</topic><topic>Receptor, Adenosine A1 - physiology</topic><topic>Receptor, Adenosine A2A - physiology</topic><topic>Theophylline - analogs & derivatives</topic><topic>Theophylline - pharmacology</topic><topic>Thioinosine - analogs & derivatives</topic><topic>Thioinosine - pharmacology</topic><topic>Time Factors</topic><topic>Triazines - pharmacology</topic><topic>Triazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pietersen, A N</creatorcontrib><creatorcontrib>Lancaster, D M</creatorcontrib><creatorcontrib>Patel, N</creatorcontrib><creatorcontrib>Hamilton, J B</creatorcontrib><creatorcontrib>Vreugdenhil, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pietersen, A N</au><au>Lancaster, D M</au><au>Patel, N</au><au>Hamilton, J B</au><au>Vreugdenhil, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modulation of gamma oscillations by endogenous adenosine through A1 and A2A receptors in the mouse hippocampus</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2009-02</date><risdate>2009</risdate><volume>56</volume><issue>2</issue><spage>481</spage><epage>492</epage><pages>481-492</pages><issn>0028-3908</issn><abstract>Adenosine serves as a homeostatic factor, regulating hippocampal activity through A(1) receptor-mediated inhibition. Gamma frequency oscillations, associated with cognitive functions, emerge from increased network activity. Here we test the hypothesis that hippocampal gamma oscillations are modulated by ambient adenosine levels. In mouse hippocampal slices exogenous adenosine suppressed the power of both kainate-induced gamma oscillations and spontaneous gamma oscillations, observed in a subset of slices in normal aCSF. Kainate-induced gamma oscillation power was suppressed by the A(1) receptor agonist PIA and potentiated by the A(1) receptor antagonist 8-CPT to three times matched control values with an EC(50) of 1.1microM. 8-CPT also potentiated spontaneous gamma oscillation power to five times control values. The A(2A) receptor agonist CGS21680 potentiated kainate-induced gamma power to two times control values (EC(50) 0.3nM), but this effect was halved in the presence of 8-CPT. The A(2A) receptor antagonist ZM241385 suppressed kainate-induced gamma power. The non-selective adenosine receptor antagonist caffeine induced gamma oscillations in slices in control aCSF and potentiated both kainate-induced gamma and spontaneous gamma oscillations to three times control values (EC(50) 28muM). Decreasing endogenous adenosine levels with adenosine deaminase increased gamma oscillations. Increasing endogenous adenosine levels with the adenosine kinase inhibitor 5-iodotubericidin suppressed gamma oscillations. Partial hypoxia-induced suppression of gamma oscillations could be prevented by 8-CPT. These observations indicate that gamma oscillation strength is powerfully modulated by ambient levels of adenosine through A(1) receptors, opposed by A(2A) receptors. Increased gamma oscillation strength is likely to contribute to the beneficial cognitive effects of caffeine.</abstract><cop>England</cop><pmid>18955071</pmid><doi>10.1016/j.neuropharm.2008.10.001</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-3908 |
ispartof | Neuropharmacology, 2009-02, Vol.56 (2), p.481-492 |
issn | 0028-3908 |
language | eng |
recordid | cdi_proquest_miscellaneous_20391074 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adenosine - analogs & derivatives Adenosine - pharmacology Adenosine A1 Receptor Antagonists Adenosine A2 Receptor Antagonists Analysis of Variance Animals Biological Clocks - drug effects Dose-Response Relationship, Drug Evoked Potentials - drug effects Evoked Potentials - physiology Excitatory Amino Acid Agonists - pharmacology Fourier Analysis Hippocampus - drug effects Hippocampus - physiology Hypoxia - physiopathology In Vitro Techniques Kainic Acid - pharmacology Male Mice Mice, Inbred C57BL Phenethylamines - pharmacology Receptor, Adenosine A1 - physiology Receptor, Adenosine A2A - physiology Theophylline - analogs & derivatives Theophylline - pharmacology Thioinosine - analogs & derivatives Thioinosine - pharmacology Time Factors Triazines - pharmacology Triazoles - pharmacology |
title | Modulation of gamma oscillations by endogenous adenosine through A1 and A2A receptors in the mouse hippocampus |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T23%3A02%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modulation%20of%20gamma%20oscillations%20by%20endogenous%20adenosine%20through%20A1%20and%20A2A%20receptors%20in%20the%20mouse%20hippocampus&rft.jtitle=Neuropharmacology&rft.au=Pietersen,%20A%20N&rft.date=2009-02&rft.volume=56&rft.issue=2&rft.spage=481&rft.epage=492&rft.pages=481-492&rft.issn=0028-3908&rft_id=info:doi/10.1016/j.neuropharm.2008.10.001&rft_dat=%3Cproquest_cross%3E20391074%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20391074&rft_id=info:pmid/18955071&rfr_iscdi=true |